Markets.com Logo

AUPH

$--
--%
1d
1w
1m

Analysis and statistics

  • Open
    11.9397$
  • Previous Close
    12.2001$
  • 52 Week Change
    6.11$
  • Day Range
    -0.26$
  • 52 Week High/Low
    6.42$ - 12.53$
  • Dividend Per Share
    --
  • Market cap
    1 581 M$
  • EPS
    0.16
  • Beta
    1.237
  • Volume
    --

About

AUPH.US is the stock ticker symbol for Aurinia Pharmaceuticals Inc. Aurinia Pharmaceuticals is a biopharmaceutical company focused on developing and commercializing therapies to treat autoimmune diseases, particularly lupus nephritis (LN). Their primary product is LUPKYNIS, a treatment for adults with active LN.

Oil Market Paradox: Geopolitical Tensions vs. Stable Prices

Ava Grace|--

US Midterm Elections: Energy Sector Outlook and Investment Implications

Ava Grace|--
Bitcoin price analysis: How much will $1 Bitcoin (BTC/USD) be worth in 2030?

Bitcoin price analysis: How much will $1 Bitcoin (BTC/USD) be worth in 2030?

Ghko B|--

Howard Marks on Market Cycles, Value Investing Logic, and Current Economic Shifts

Sophia Claire|--
EUR/USD Forecast: EUR/USD Eyes Key Resistance, Will the Dollar Bounce or Continue to Slide?

EUR/USD Forecast: EUR/USD Eyes Key Resistance, Will the Dollar Bounce or Continue to Slide?

Ghko B|--

Market Resilience Amidst Geopolitical Tensions: HSBC's Optimistic Strategic Outlook

Sophia Claire|--
Apple stock analysis: Could Apple stock soar under its new CEO John Ternus?

Apple stock analysis: Could Apple stock soar under its new CEO John Ternus?

Ghko B|--

Factors

Clinical Trial Results: Positive data from Aurinia's clinical trials for Lupkynis (voclosporin) typically leads to increased investor confidence and a higher stock price. Conversely, negative or inconclusive results can cause a significant drop.

Regulatory Approvals: FDA or other regulatory agency approvals of Lupkynis for new indications or in different geographical regions usually drive the stock price upward, signaling expanded market potential.

Sales Performance: Strong sales figures for Lupkynis and revenue growth generally translate to higher stock value, reflecting the company's commercial success and profitability. Missed sales targets can negatively impact the price.

Competition: The presence of competing treatments for lupus nephritis and their market share can influence investor sentiment toward Aurinia. New entrants or superior efficacy of other drugs may lower AUPH's price.

Partnerships and Acquisitions: Potential partnerships, licensing agreements, or acquisition interest in Aurinia can create speculation and potentially boost the stock price. Failed deals can have the opposite effect.

Market Conditions: General market sentiment, macroeconomic factors, and industry trends in the pharmaceutical or biotechnology sectors can impact AUPH's stock price, irrespective of company-specific news.

Analyst Ratings: Upgrades from financial analysts often attract more investors and push the price higher, while downgrades may lead to selling pressure and a price decrease.

Financial Health: The company's cash position, debt levels, and overall financial stability play a role in investor confidence. A strong balance sheet can support a higher valuation.

Patent Protection: The strength and duration of Aurinia's patents for Lupkynis contribute to its competitive advantage. Patent expirations or challenges can negatively affect the stock price.

Management Team: Confidence in Aurinia's leadership and their ability to execute the company's strategy is important for investor sentiment. Changes in management can sometimes impact the stock price.

People Also Watch

Latest news

Fed Leadership Uncertainty: Powell's Potential Continuation and Political Hurdles

Ava Grace|--

Gerrymandering Backfires: Republicans Fear Election Losses as Districts Are Redrawn

Emma Rose|--

Fed Nomination Stalemate: Republican Opposition Halts Warsh's Senate Confirmation

Sophia Claire|--

Latest Education Articles

What Are Non-Farm Payrolls? A Simple Guide for Traders

What Are Non-Farm Payrolls? A Simple Guide for Traders

Julian Parker|--
What Is Spread Betting and How Does It Work? A Clear Guide for Traders

What Is Spread Betting and How Does It Work? A Clear Guide for Traders

Julian Parker|--
What Drives Cryptocurrency Prices? 8 Key Factors Traders Should Know

What Drives Cryptocurrency Prices? 8 Key Factors Traders Should Know

Julian Parker|--
Recommended Topics